Stellantis’ Market Value Halves In 2024: Why CEO Tavares’ Exit Could Take Things From Bad To Worse
Stellantis struggles in 2024, with stock down 47%, CEO Carlos Tavares’ unexpected resignation and challenges in EV sales and competition. Analysts warn of leadership uncertainty and internal/external pressures. read more
Analyst Expectations For Norwegian Cruise Line’s Future
Latest Ratings for NCLH Date Firm Action From To Mar 2022 Macquarie Maintains Outperform Feb 2022 Deutsche Bank Maintains Hold Feb 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for NCLH View the Latest Analyst Ratings read more
The Latest Analyst Ratings For Progyny
Latest Ratings for PGNY Date Firm Action From To Dec 2021 Jefferies Initiates Coverage On Buy Sep 2021 Berenberg Initiates Coverage On Buy Sep 2021 Barclays Maintains Overweight View More Analyst Ratings for PGNY View the Latest Analyst Ratings read more
Key Takeaways From AnaptysBio Analyst Ratings
Latest Ratings for ANAB Date Firm Action From To Mar 2022 HC Wainwright & Co. Maintains Buy Jun 2021 HC Wainwright & Co. Initiates Coverage On Buy May 2021 UBS Initiates Coverage On Neutral View More Analyst Ratings for ANAB View the Latest Analyst Ratings read more
Demystifying Marqeta: Insights From 9 Analyst Reviews
Latest Ratings for MQ Date Firm Action From To Mar 2022 JP Morgan Maintains Overweight Mar 2022 Truist Securities Maintains Buy Mar 2022 Keefe, Bruyette & Woods Maintains Market Perform View More Analyst Ratings for MQ View the Latest Analyst Ratings read more
Expert Ratings For HealthEquity
Latest Ratings for HQY Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Dec 2021 JP Morgan Maintains Overweight Dec 2021 Deutsche Bank Maintains Buy View More Analyst Ratings for HQY View the Latest Analyst Ratings read more
